Women’s Health and Menopause: Risk Reduction Strategies
Despite its universality in human female aging, the menopause and its biology are not completely understood. New biologic mechanisms by which sex hormones may be detrimental or confer protection are continually being discovered. We are now starting to understand that the role of the estrogen recepto...
Gespeichert in:
Weitere Verfasser: | , , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Dordrecht
Springer Netherlands
1997
|
Schriftenreihe: | Medical Science Symposia Series
11 |
Schlagworte: | |
Online-Zugang: | UBR01 URL des Erstveröffentlichers |
Zusammenfassung: | Despite its universality in human female aging, the menopause and its biology are not completely understood. New biologic mechanisms by which sex hormones may be detrimental or confer protection are continually being discovered. We are now starting to understand that the role of the estrogen receptor is not identical in all tissues. Important nongenomic effects for sex hormones have also been described. Hormone replacement therapy (HRT) has produced effects on health risks: some are reduced, some are increased, and the rest remain uncertain. HRT is being used by an increasing number of women to alleviate climacteric symptoms in the perimenopausal period and to prevent osteoporosis and cardiovascular disease later. Positive effects on Alzheimer's disease and dementia on the one hand, and an increase in venous thrombosis on the other, are currently being reported by several groups. Both the preventive benefits and the risk of breast cancer seem to be linked to long-term and current use. HRT requires further testing through specific clinical trials, currently underway in the United States, before confident recommendations may be made about the full range of benefits and risks |
Beschreibung: | 1 Online-Ressource (XXIX, 341 p) |
ISBN: | 9789401155601 |
DOI: | 10.1007/978-94-011-5560-1 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV046144934 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1997 |||| o||u| ||||||eng d | ||
020 | |a 9789401155601 |9 978-94-011-5560-1 | ||
024 | 7 | |a 10.1007/978-94-011-5560-1 |2 doi | |
035 | |a (ZDB-2-SME)978-94-011-5560-1 | ||
035 | |a (OCoLC)1119034992 | ||
035 | |a (DE-599)BVBBV046144934 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 618.1 |2 23 | |
245 | 1 | 0 | |a Women’s Health and Menopause |b Risk Reduction Strategies |c edited by R. Paoletti, P. G. Crosignani, P. Kenemans, G. Samsioe, M. R. Soma, A. S. Jackson |
264 | 1 | |a Dordrecht |b Springer Netherlands |c 1997 | |
300 | |a 1 Online-Ressource (XXIX, 341 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Medical Science Symposia Series |v 11 | |
520 | |a Despite its universality in human female aging, the menopause and its biology are not completely understood. New biologic mechanisms by which sex hormones may be detrimental or confer protection are continually being discovered. We are now starting to understand that the role of the estrogen receptor is not identical in all tissues. Important nongenomic effects for sex hormones have also been described. Hormone replacement therapy (HRT) has produced effects on health risks: some are reduced, some are increased, and the rest remain uncertain. HRT is being used by an increasing number of women to alleviate climacteric symptoms in the perimenopausal period and to prevent osteoporosis and cardiovascular disease later. Positive effects on Alzheimer's disease and dementia on the one hand, and an increase in venous thrombosis on the other, are currently being reported by several groups. Both the preventive benefits and the risk of breast cancer seem to be linked to long-term and current use. HRT requires further testing through specific clinical trials, currently underway in the United States, before confident recommendations may be made about the full range of benefits and risks | ||
650 | 4 | |a Gynecology | |
650 | 4 | |a Biochemistry, general | |
650 | 4 | |a Epidemiology | |
650 | 4 | |a Public Health | |
650 | 4 | |a Gynecology | |
650 | 4 | |a Biochemistry | |
650 | 4 | |a Epidemiology | |
650 | 0 | 7 | |a Postmenopause |0 (DE-588)4175456-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Prävention |0 (DE-588)4076308-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Alterskrankheit |0 (DE-588)4132293-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Östrogene |0 (DE-588)4075616-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Hormontherapie |0 (DE-588)4025870-1 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Postmenopause |0 (DE-588)4175456-6 |D s |
689 | 0 | 1 | |a Östrogene |0 (DE-588)4075616-6 |D s |
689 | 0 | 2 | |a Hormontherapie |0 (DE-588)4025870-1 |D s |
689 | 0 | 3 | |a Alterskrankheit |0 (DE-588)4132293-9 |D s |
689 | 0 | 4 | |a Prävention |0 (DE-588)4076308-0 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Paoletti, R. |4 edt | |
700 | 1 | |a Crosignani, P. G. |4 edt | |
700 | 1 | |a Kenemans, P. |4 edt | |
700 | 1 | |a Samsioe, G. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792346975 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401155618 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401063432 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-94-011-5560-1 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031525119 | ||
966 | e | |u https://doi.org/10.1007/978-94-011-5560-1 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180480959971328 |
---|---|
any_adam_object | |
author2 | Paoletti, R. Crosignani, P. G. Kenemans, P. Samsioe, G. |
author2_role | edt edt edt edt |
author2_variant | r p rp p g c pg pgc p k pk g s gs |
author_facet | Paoletti, R. Crosignani, P. G. Kenemans, P. Samsioe, G. |
building | Verbundindex |
bvnumber | BV046144934 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-94-011-5560-1 (OCoLC)1119034992 (DE-599)BVBBV046144934 |
dewey-full | 618.1 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 618 - Gynecology, obstetrics, pediatrics, geriatrics |
dewey-raw | 618.1 |
dewey-search | 618.1 |
dewey-sort | 3618.1 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-94-011-5560-1 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03662nmm a2200661zcb4500</leader><controlfield tag="001">BV046144934</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1997 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401155601</subfield><subfield code="9">978-94-011-5560-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-011-5560-1</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-011-5560-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119034992</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144934</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">618.1</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Women’s Health and Menopause</subfield><subfield code="b">Risk Reduction Strategies</subfield><subfield code="c">edited by R. Paoletti, P. G. Crosignani, P. Kenemans, G. Samsioe, M. R. Soma, A. S. Jackson</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XXIX, 341 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Medical Science Symposia Series</subfield><subfield code="v">11</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Despite its universality in human female aging, the menopause and its biology are not completely understood. New biologic mechanisms by which sex hormones may be detrimental or confer protection are continually being discovered. We are now starting to understand that the role of the estrogen receptor is not identical in all tissues. Important nongenomic effects for sex hormones have also been described. Hormone replacement therapy (HRT) has produced effects on health risks: some are reduced, some are increased, and the rest remain uncertain. HRT is being used by an increasing number of women to alleviate climacteric symptoms in the perimenopausal period and to prevent osteoporosis and cardiovascular disease later. Positive effects on Alzheimer's disease and dementia on the one hand, and an increase in venous thrombosis on the other, are currently being reported by several groups. Both the preventive benefits and the risk of breast cancer seem to be linked to long-term and current use. HRT requires further testing through specific clinical trials, currently underway in the United States, before confident recommendations may be made about the full range of benefits and risks</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gynecology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epidemiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Public Health</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gynecology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epidemiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Postmenopause</subfield><subfield code="0">(DE-588)4175456-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Alterskrankheit</subfield><subfield code="0">(DE-588)4132293-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Östrogene</subfield><subfield code="0">(DE-588)4075616-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hormontherapie</subfield><subfield code="0">(DE-588)4025870-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Postmenopause</subfield><subfield code="0">(DE-588)4175456-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Östrogene</subfield><subfield code="0">(DE-588)4075616-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Hormontherapie</subfield><subfield code="0">(DE-588)4025870-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Alterskrankheit</subfield><subfield code="0">(DE-588)4132293-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Paoletti, R.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Crosignani, P. G.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kenemans, P.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Samsioe, G.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792346975</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401155618</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401063432</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-011-5560-1</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031525119</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-011-5560-1</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV046144934 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:26Z |
institution | BVB |
isbn | 9789401155601 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031525119 |
oclc_num | 1119034992 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XXIX, 341 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1997 |
publishDateSearch | 1997 |
publishDateSort | 1997 |
publisher | Springer Netherlands |
record_format | marc |
series2 | Medical Science Symposia Series |
spelling | Women’s Health and Menopause Risk Reduction Strategies edited by R. Paoletti, P. G. Crosignani, P. Kenemans, G. Samsioe, M. R. Soma, A. S. Jackson Dordrecht Springer Netherlands 1997 1 Online-Ressource (XXIX, 341 p) txt rdacontent c rdamedia cr rdacarrier Medical Science Symposia Series 11 Despite its universality in human female aging, the menopause and its biology are not completely understood. New biologic mechanisms by which sex hormones may be detrimental or confer protection are continually being discovered. We are now starting to understand that the role of the estrogen receptor is not identical in all tissues. Important nongenomic effects for sex hormones have also been described. Hormone replacement therapy (HRT) has produced effects on health risks: some are reduced, some are increased, and the rest remain uncertain. HRT is being used by an increasing number of women to alleviate climacteric symptoms in the perimenopausal period and to prevent osteoporosis and cardiovascular disease later. Positive effects on Alzheimer's disease and dementia on the one hand, and an increase in venous thrombosis on the other, are currently being reported by several groups. Both the preventive benefits and the risk of breast cancer seem to be linked to long-term and current use. HRT requires further testing through specific clinical trials, currently underway in the United States, before confident recommendations may be made about the full range of benefits and risks Gynecology Biochemistry, general Epidemiology Public Health Biochemistry Postmenopause (DE-588)4175456-6 gnd rswk-swf Prävention (DE-588)4076308-0 gnd rswk-swf Alterskrankheit (DE-588)4132293-9 gnd rswk-swf Östrogene (DE-588)4075616-6 gnd rswk-swf Hormontherapie (DE-588)4025870-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Postmenopause (DE-588)4175456-6 s Östrogene (DE-588)4075616-6 s Hormontherapie (DE-588)4025870-1 s Alterskrankheit (DE-588)4132293-9 s Prävention (DE-588)4076308-0 s DE-604 Paoletti, R. edt Crosignani, P. G. edt Kenemans, P. edt Samsioe, G. edt Erscheint auch als Druck-Ausgabe 9780792346975 Erscheint auch als Druck-Ausgabe 9789401155618 Erscheint auch als Druck-Ausgabe 9789401063432 https://doi.org/10.1007/978-94-011-5560-1 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Women’s Health and Menopause Risk Reduction Strategies Gynecology Biochemistry, general Epidemiology Public Health Biochemistry Postmenopause (DE-588)4175456-6 gnd Prävention (DE-588)4076308-0 gnd Alterskrankheit (DE-588)4132293-9 gnd Östrogene (DE-588)4075616-6 gnd Hormontherapie (DE-588)4025870-1 gnd |
subject_GND | (DE-588)4175456-6 (DE-588)4076308-0 (DE-588)4132293-9 (DE-588)4075616-6 (DE-588)4025870-1 (DE-588)1071861417 |
title | Women’s Health and Menopause Risk Reduction Strategies |
title_auth | Women’s Health and Menopause Risk Reduction Strategies |
title_exact_search | Women’s Health and Menopause Risk Reduction Strategies |
title_full | Women’s Health and Menopause Risk Reduction Strategies edited by R. Paoletti, P. G. Crosignani, P. Kenemans, G. Samsioe, M. R. Soma, A. S. Jackson |
title_fullStr | Women’s Health and Menopause Risk Reduction Strategies edited by R. Paoletti, P. G. Crosignani, P. Kenemans, G. Samsioe, M. R. Soma, A. S. Jackson |
title_full_unstemmed | Women’s Health and Menopause Risk Reduction Strategies edited by R. Paoletti, P. G. Crosignani, P. Kenemans, G. Samsioe, M. R. Soma, A. S. Jackson |
title_short | Women’s Health and Menopause |
title_sort | women s health and menopause risk reduction strategies |
title_sub | Risk Reduction Strategies |
topic | Gynecology Biochemistry, general Epidemiology Public Health Biochemistry Postmenopause (DE-588)4175456-6 gnd Prävention (DE-588)4076308-0 gnd Alterskrankheit (DE-588)4132293-9 gnd Östrogene (DE-588)4075616-6 gnd Hormontherapie (DE-588)4025870-1 gnd |
topic_facet | Gynecology Biochemistry, general Epidemiology Public Health Biochemistry Postmenopause Prävention Alterskrankheit Östrogene Hormontherapie Konferenzschrift |
url | https://doi.org/10.1007/978-94-011-5560-1 |
work_keys_str_mv | AT paolettir womenshealthandmenopauseriskreductionstrategies AT crosignanipg womenshealthandmenopauseriskreductionstrategies AT kenemansp womenshealthandmenopauseriskreductionstrategies AT samsioeg womenshealthandmenopauseriskreductionstrategies |